Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macey, D. J.
Right arrow Articles by Pitkanen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macey, D. J.
Right arrow Articles by Pitkanen, M.

Stroke, Vol 13, 519-521, Copyright © 1982 by American Heart Association


ARTICLES

Analysis of the gamma ray spectra recorded in the use of Xenon-133 for cerebral blood flow studies

DJ Macey, LJ Filipow, ST McCarthy and M Pitkanen

A problem in the measurement of cerebral blood flow with 133Xenon is the presence of extra-cerebral counts in the total counts recorded with a collimated gamma ray detector looking at the brain. A method of studying qualitatively the contribution of this extra-cranial component in patients is described. This entails the sequential accumulation of gamma ray spectra recorded during the clearance phase of 133Xenon from the brain. It is shown that different CBF indices are obtained for various regions of the recorded gamma ray spectra. The principal component of the extra-cerebral counts at 15 minutes postinjection appears to be intra-cranial, and not the scalp as assumed previously in the spectrum subtraction method.